期刊文献+

原发性开角型青光眼药物治疗后单次眼压达目标眼压的安全性——附37眼分析 被引量:4

下载PDF
导出
摘要 目的:探讨原发性开角型青光眼(primary open angle glaucoma,POAG)患者药物治疗后单次眼压达目标眼压的安全性。方法:对经药物治疗后单次眼压达目标眼压的POAG患者24例(37眼)采用Goldmann压平眼压计进行日间眼压监测和饮水试验,观察其眼压最高值情况。结果:①日间眼压监测:眼压最高值超过17mmHg9眼(24%),其中超过19mmHg5眼(14%),眼压最高值为21mmHg1眼(3%)。②饮水试验:眼压最高值超过17mmHg16眼(43%),其中超过19mmHg12眼(32%),超过21mmHg7眼(19%)。结论:原发性开角型青光眼药物治疗后单次眼压达目标眼压仍未安全,应测量多次眼压并作相应处理,使眼压峰值保持在目标眼压范围内,以防止视神经的进一步损害。
出处 《新医学》 2009年第1期39-41,共3页 Journal of New Medicine
  • 相关文献

参考文献9

  • 1余敏斌,李劲嵘.青光眼药物治疗的新概念[J].中华眼科杂志,2006,42(3):283-288. 被引量:52
  • 2雷帅臣.恶性青光眼治疗方法探讨[J].中山大学学报(医学科学版),2005,26(B03):255-256. 被引量:7
  • 3O'BRIEN C, SCHWARTZ B, TAKAMOTO T, et al. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma [ J ]. Am J Ophthalmol, 1991, 111 (4):491-500.
  • 4CHAUHAN B C, DRANCE S M. The relationship between intraocular pressure and visual field progression in glaucoma [ J ]. Graefes Arch Clin Exp Ophthalmol, 1992, 230 (6): 521-526.
  • 5曾绮玲,邓奋刚,金敏,杨为中.两种手术方法治疗晶状体源性青光眼的疗效比较──附78例报告[J].新医学,2002,33(6):338-339. 被引量:1
  • 6JONAS J B, BUDDE W, STROUX A, et al. Single intraocular pressure measurements and diurnal intraocular pressure profiles [ J] . Am J Ophthalmol, 2005, 139 (6) : 1136-1137.
  • 7ASRANI S, ZEIMER R, WILENSKY J, et al. Large diurnal fluctuations in intraocular pressure are an independent.risk factor in patients with glaucoma [ J]. J Glaucoma, 2000, 9 (2) : 134-142.
  • 8MARTINEZ-BELLO C, CHAUHAN B C, NICOLELA M T, et al. Intraocular pressure and progression of glaucomatous visual field loss [ J ]. Am J Ophthalmol, 2000, 129 (3) : 302-308.
  • 9ARMALY M F, KRUEGER D E, MAUNDER L, et al.Biostatistical analysis of the collaborative glaucoma study. I. summary report of the risk factors for glaucomatous visual- field defects [ J ] . Arch Ophthalmol, 1980, 98(12) : 2163-2171.

二级参考文献26

  • 1方敏,余敏斌.高眼压症认识新进展[J].国外医学(眼科学分册),2004,28(5):312-316. 被引量:22
  • 2葛坚.我国近五年青光眼临床与基础研究进展[J].中华眼科杂志,2005,41(8):710-716. 被引量:150
  • 3李国彦 魏厚仁.青光眼的诊断与治疗[M].武汉:湖北科技出版社,1988.30-187.
  • 4周文炳,主编.临床青光眼.北京:人民卫生出版社,1998.337-362.
  • 5Michaud JE,Friren B.Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.Am J Ophthalmol,2001,132:235-243.
  • 6Netland PA,Landry T,Sullivan EK,et al.Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.Am J Ophthalmol,2001,132:472-484.
  • 7Richard KP.A comparison of latanoprost,bimatoprost and travoprost in patients with elevated intraocular pressure:a 12-week,randomized,masked-evaluator multicenter study.Am J Ophthalmol,2004,137:387-388.
  • 8Leske MC,Heijl A,Hyman L,et al.Early manifest glaucoma trial:design and baseline data.Ophthalmology,1999,106:2144-2153.
  • 9Leske MC,Heijl A,Hussein M,et al.Factors for glaucoma progression and the effect of treatment:the early manifest glaucoma trial.Arch Ophthalmol,2003,121:48-56.
  • 10Leskea MC,Heijl A,Hyman L,et al.Factors for progression and glaucoma treatment:the early manifest glaucoma trial.Curr Opin Ophthalmol,2004,15:102-106.

共引文献57

同被引文献13

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部